5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR THE TREATMENT OF MYOCARDIAL INFARCTION

摘要

The present invention relates to the field of myocardial infraction (MI). It more specifically relates to an agent stimulating, either directly or indirectly, the 5-hydroxytryptamine 1B receptor, and to a composition comprising said agent, for use in the treatment of a patient having a myocardial infraction (MI). The invention further encompasses therapeutic and screening methods.